Mucosal Vaccination for Influenza Protection Enhanced by Catalytic Immune‐Adjuvant

Influenza poses a severe threat to global health. Despite the whole inactivated virus (WIV)‐based nasal vaccine being a promising strategy for influenza protection, the mucosal barrier is still a bottleneck of the nasal vaccine. Here, a catalytic mucosal adjuvant strategy for an influenza WIV nasal...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Tao, Ma, Shang, Miao, Xinyu, Tang, Yan, Huangfu, Dandan, Wang, Jinyuan, Jiang, Jing, Xu, Nuo, Yin, Yuncong, Chen, Sujuan, Liu, Xiufan, Yin, Yinyan, Peng, Daxin, Gao, Lizeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509716/
https://www.ncbi.nlm.nih.gov/pubmed/32999833
http://dx.doi.org/10.1002/advs.202000771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509716/
https://www.ncbi.nlm.nih.gov/pubmed/32999833
http://dx.doi.org/10.1002/advs.202000771

Ejemplares similares